A qualified nuclear medicine physician with more than 20 years’ experience in bioscience research and innovation, Dr George Syrmalis knew that to create the medicines of tomorrow, he had to design a new kind of enterprise.

In 2011, Dr Syrmalis founded The iQ Group Global in Sydney, to converge investment banking, scientific discovery, corporate advisory and commercialisation to bring medical innovations to the world. A diverse team of experts, they work together to find, fund, and develop bioscience discoveries into life-changing medical innovations – and take them to the people who need them most. With four listings on two stock exchanges and expertise in private banking, financial planning, and equities analysis, The iQ Group Global creates opportunities to bring unique innovations to global healthcare markets.

“At The iQ Group Global, our diverse expertise creates new paths leading to the edge of human discovery. What starts here changes the word,” CEO Dr George Syrmalis said.